Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | E3 ubiquitin-protein ligase Mdm2 | ||
Ligand | BDBM135436 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | FRET Assay | ||
IC50 | 1±n/a nM | ||
Citation | Christopher, MP; Fradera Llinas, FX; Machacek, M; Martinez, M; Reutershan, MH; Shizuka, M; Sun, B; Thompson, CF; Trotter, BW; Voss, ME; Altman, MD; Bogen, SL; Doll, RJ Substituted imidazopyridines as HDM2 inhibitors US Patent US8846657 Publication Date 9/30/2014 | ||
More Info.: | Get all data from this article, Assay Method | ||
E3 ubiquitin-protein ligase Mdm2 | |||
Name: | E3 ubiquitin-protein ligase Mdm2 | ||
Synonyms: | Double minute 2 protein | Double minute 2 protein (HDM2) | E3 ubiquitin-protein ligase Mdm2 (p53-binding protein Mdm2) | Hdm2 | Human Double Minute 2 (HDM2) | MDM2 | MDM2-MDMX | MDM2_HUMAN | p53-Binding Protein MDM2 | p53-binding protein | ||
Type: | Oncoprotein | ||
Mol. Mass.: | 55196.54 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q00987 | ||
Residue: | 491 | ||
Sequence: |
| ||
BDBM135436 | |||
n/a | |||
Name | BDBM135436 | ||
Synonyms: | US8846657, 18.4 | ||
Type | Small organic molecule | ||
Emp. Form. | C30H36ClN7O5 | ||
Mol. Mass. | 610.104 | ||
SMILES | C[C@H]1CC[C@H](Cn2c(nc3cc(nc(-c4cc(Cl)cnc4OCCO)c23)-c2noc(=O)[nH]2)N2CCO[C@@H]3CCC[C@@H]23)CC1 |r,wU:36.40,4.4,wD:40.43,1.0,(7.31,-5.23,;5.97,-4.46,;5.97,-2.92,;4.64,-2.15,;3.3,-2.92,;1.97,-2.15,;1.97,-.61,;2.88,.64,;1.97,1.88,;.51,1.41,;-.83,2.18,;-2.16,1.41,;-2.16,-.13,;-.83,-.9,;-.83,-2.44,;.51,-3.21,;.51,-4.75,;1.84,-5.52,;-.83,-5.52,;-2.16,-4.75,;-2.16,-3.21,;-3.49,-2.44,;-4.83,-3.21,;-6.16,-2.44,;-7.5,-3.21,;.51,-.13,;-3.49,2.18,;-4.96,1.7,;-5.86,2.95,;-4.96,4.19,;-5.73,5.52,;-3.49,3.72,;4.42,.64,;5.19,-.7,;6.73,-.7,;7.5,.64,;6.73,1.97,;7.2,3.43,;5.96,4.34,;4.71,3.43,;5.19,1.97,;3.3,-4.46,;4.64,-5.23,)| | ||
Structure |